Skip to content

Study of efficacy and safety of KSM-66 Ashwagandhaa (Withania somnifera Dunal) in stress and anxiety and on general well being in healthy adults.

A Single Centre, Prospective, Randomized, Double-blind Placebo Controlled Study of Safety And Efficacy of KSM-66 in Healthy Adults.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/091/000222
Enrollment
60
Registered
2011-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ksm66 ashwagandhaa: 250 mg orally BID for 8 weeks Control Intervention1: Placebo: same

Sponsors

Ixoreal Biomed Priavte Limited, #5-9-225, 3rd floor, Sanali estate, Chirag ali lane, Abids, Hyderabad, Andhra Pradesh- 500001, India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ? Healthy adults of either sex, who are facing routine work stresses, who sign the Informed Consent Form. ? Age group 18 -54 years ? Can read , write and understand English ? Subjects with WHO-5 well being index < 15 or PSS scores >14

Exclusion criteria

Exclusion criteria: ? Suffering from any chronic physical, hormonal or psychiatric illness ? Current substance dependence ? Individuals refusing to use appropriate non-hormonal birth control measures. ? Pregnancy / lactating mothers ? Currently taking any other medication on a regular basis ? Currently taking any herbal preparations (other formulations containing ashwagandha / ginseng / ginkgo biloba / brahmi etc) ? Clinically significant findings on laboratory investigations and ECG

Design outcomes

Primary

MeasureTime frame
Total score on DASS and GHQ-28 after 8 wkTimepoint: 0 day, 60 day

Secondary

MeasureTime frame
Comparison of the study and control group on PSS scores Comparison of the study and control groups on various laboratory measures and serum cortisol levels Comparison of the study and control group on PSS scores Comparison of the study and control groups on various laboratory measures and serum cortisol levels Timepoint: 0 day and 60 day

Countries

India

Contacts

Public ContactDr.Shridhar Anishetty
shridhar_anishetty@ixoreal.com04064513818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026